1. Home
  2. ANVS vs NVNI Comparison

ANVS vs NVNI Comparison

Compare ANVS & NVNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • NVNI
  • Stock Information
  • Founded
  • ANVS 2008
  • NVNI 2019
  • Country
  • ANVS United States
  • NVNI Brazil
  • Employees
  • ANVS N/A
  • NVNI N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • NVNI
  • Sector
  • ANVS Health Care
  • NVNI
  • Exchange
  • ANVS Nasdaq
  • NVNI Nasdaq
  • Market Cap
  • ANVS 55.5M
  • NVNI 57.2M
  • IPO Year
  • ANVS 2020
  • NVNI N/A
  • Fundamental
  • Price
  • ANVS $2.34
  • NVNI $0.55
  • Analyst Decision
  • ANVS Strong Buy
  • NVNI
  • Analyst Count
  • ANVS 4
  • NVNI 0
  • Target Price
  • ANVS $17.33
  • NVNI N/A
  • AVG Volume (30 Days)
  • ANVS 231.9K
  • NVNI 2.8M
  • Earning Date
  • ANVS 11-07-2025
  • NVNI 09-30-2025
  • Dividend Yield
  • ANVS N/A
  • NVNI N/A
  • EPS Growth
  • ANVS N/A
  • NVNI N/A
  • EPS
  • ANVS N/A
  • NVNI N/A
  • Revenue
  • ANVS N/A
  • NVNI $31,250,627.00
  • Revenue This Year
  • ANVS N/A
  • NVNI $12.05
  • Revenue Next Year
  • ANVS N/A
  • NVNI $15.02
  • P/E Ratio
  • ANVS N/A
  • NVNI N/A
  • Revenue Growth
  • ANVS N/A
  • NVNI 1491.58
  • 52 Week Low
  • ANVS $1.11
  • NVNI $0.14
  • 52 Week High
  • ANVS $10.54
  • NVNI $12.19
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 43.00
  • NVNI 47.70
  • Support Level
  • ANVS $2.21
  • NVNI $0.52
  • Resistance Level
  • ANVS $2.51
  • NVNI $0.66
  • Average True Range (ATR)
  • ANVS 0.13
  • NVNI 0.05
  • MACD
  • ANVS -0.01
  • NVNI -0.02
  • Stochastic Oscillator
  • ANVS 25.35
  • NVNI 19.53

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About NVNI Nvni Group Limited

Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.

Share on Social Networks: